Generic Name

Midazolam

Brand Names
Seizalam, Nayzilam
FDA approval date: June 20, 2000
Classification: Benzodiazepine
Form: Injection, Spray, Syrup

What is Seizalam (Midazolam)?

Midazolam HCl Syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. Midazolam HCl syrup is intended for use in monitored settings only and not for chronic or home use. WARNINGS MIDAZOLAM HCL SYRUP MUST BE USED AS SPECIFIED IN THE LABEL. Midazolam is associated with a high incidence of partial or complete impairment of recall for the next several hours. CLINICAL PHARMACOLOGY.

Top Global Experts

There are no experts for this drug

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

There is no latest advances for this treatment

Brand Information

    Seizalam has been selected.